Utility of coronary revascularization in patients with ischemic left ventricular dysfunction.
Mohammed Al-SadawiMichael TaoSimrat DhaliwalArchanna RadakrishnanYang LiuChad GierRavi MassonTahmid RahmanEdlira TamNoelle MannPublished in: Cardiovascular revascularization medicine : including molecular interventions (2024)
Revascularization in patients with ischemic LV dysfunction is associated with lower risk of all-cause and CV mortality independent of severity of LV dysfunction or method of revascularization. Revascularization is not associated with lower risk of mortality in patients without evidence of viable myocardium and is not associated with lower risk of AMI or HF hospitalization.
Keyphrases
- percutaneous coronary intervention
- coronary artery bypass grafting
- acute myocardial infarction
- coronary artery disease
- left ventricular
- oxidative stress
- end stage renal disease
- cardiovascular events
- ejection fraction
- newly diagnosed
- aortic stenosis
- chronic kidney disease
- ischemia reperfusion injury
- heart failure
- acute coronary syndrome
- peritoneal dialysis
- cardiovascular disease
- type diabetes
- hypertrophic cardiomyopathy
- mitral valve
- cardiac resynchronization therapy
- atrial fibrillation
- patient reported outcomes
- blood brain barrier